DongBang Medical

동방메디컬 · 240550

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$98M (₩135.2B)

Overview

DongBang Medical makes single-use acupuncture needles and cupping cups used in traditional Korean medicine, as well as aesthetic medical devices such as hyaluronic acid dermal fillers, cannulas, needles, and biodegradable absorbable sutures.

Its products reach hospitals, pharmaceutical companies, and distributors both domestically and across more than fifty countries spanning Asia, North America, South America, and Europe. Listed on KOSDAQ, Korea's tech and small-cap board, the company operates across two main product lines, traditional Korean medical devices and aesthetic medical devices, with the aesthetic segment, particularly dermal fillers, representing a growing share of its business.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$82.3M
▲ +8.0% YoY
Operating profit · FY2025
US$12.3M
▲ +13.0% YoY
Net income · FY2025
US$8.3M
▲ +265.9% YoY

Revenue

  • FY2024US$76.2M
  • FY2025US$82.3M

Operating profit

  • FY2024US$10.9M
  • FY2025US$12.3M

Net income

  • FY2024US$2.3M
  • FY2025US$8.3M

Key ratios (FY2025)

ROE
9.1%
Debt/Eq
48.9%
Op. margin
15.0%
Net margin
10.1%
Rev. YoY
▲ +8.0%

Why it matters

DongBang Medical participated as the domestic manufacturer representative in drafting the international single-use sterile acupuncture needle standard, which has since been adopted as a Korean national standard.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.